Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Palbociclib Impurity 002 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Pack Sizes: 2 mg. Product ID: B2694-338792. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Palbociclib Impurity 022 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 1779124-68-3. Pack Sizes: 100 mg. Product ID: B2694-338796. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 025 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 2174002-16-3. Pack Sizes: 2 mg. Product ID: B2694-338798. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 026 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Pack Sizes: 2 mg. Product ID: B2694-037182. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 027 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Pack Sizes: 2 mg. Product ID: B2694-338802. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 028 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Pack Sizes: 2 mg. Product ID: B2694-338803. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 029 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 1566082-34-5. Pack Sizes: 2 mg. Product ID: B2694-338800. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 030 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 1211541-02-4. Pack Sizes: 2 mg. Product ID: B2694-338799. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 10 | Palbociclib Impurity 10 is an impurity of Palbociclib, which is a selective cyclin-dependent kinases CDK4 and CDK6 inhibitor used for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 2206135-30-8. Pack Sizes: 2 mg. Product ID: B2694-338793. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 2 | Palbociclib Impurity 2 is an impurity of Palbociclib, which is a selective cyclin-dependent kinases CDK4 and CDK6 inhibitor used for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 2204863-06-7. Pack Sizes: 5 mg. Product ID: B2694-338794. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 4 | An impurity of Palbociclib which is a selective cyclin-dependent kinase (CDK) 4/6 inhibitor to treat ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 1376615-91-6. Pack Sizes: 10 mg. Product ID: B2694-478516. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity F | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 1023594-49-1. Pack Sizes: 100 mg. Product ID: B2694-338797. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 1,4-Bis(4-nitrophenyl)piperazine | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 16264-05-4. Pack Sizes: 100 mg. Product ID: B1476-166965. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 5-bromo-4-chloro-N-cyclopentylpyrimidin-2-amine | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 1823404-28-9. Pack Sizes: 100 mg. Product ID: B1476-284923. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 6-Bromo-8-cyclopentyl-2-[[5-(4-Boc-1-piperazinyl)-2-pyridyl]amino]-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 571188-82-4. Pack Sizes: 100 mg. Product ID: B1476-282703. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 6-Desacetyl-6-Bromo Palbociclib | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 851067-56-6. Pack Sizes: 100 mg. Product ID: B1476-283285. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 6-Desacetyl-6-Bromo Palbociclib Hydrochloride | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 850918-83-1. Pack Sizes: 100 mg. Product ID: B1476-284929. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 6-Desacetyl Palbociclib | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 571190-22-2. Pack Sizes: 100 mg. Product ID: B1476-478511. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 6-Desacetyl Palbociclib Hydrochloride | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 571189-66-7. Pack Sizes: 100 mg. Product ID: B1476-284928. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pabociclib Impurity B | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 1651214-74-2. Pack Sizes: 100 mg. Product ID: B1476-478509. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pabociclib Impurity B Hydrochloride | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 1883672-48-7. Pack Sizes: 100 mg. Product ID: B1476-284924. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Pyridine N-Oxide | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 2098673-40-4. Pack Sizes: 10 mg. Product ID: B2694-376322. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tert-butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 866084-31-3. Pack Sizes: 100 mg. Product ID: B1476-283415. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-6-vinyl-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 1941177-45-2. Pack Sizes: 2 mg. Product ID: B2694-338795. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 571189-65-6. Pack Sizes: 100 mg. Product ID: B1476-284927. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tri-O-tolylphosphine oxide | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 6163-63-9. Pack Sizes: 100 mg. Product ID: B1476-318503. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
